These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9512135)

  • 21. Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.
    Sim H; Yim C; Krajden M; Heathcote J
    Am J Gastroenterol; 1998 Jan; 93(1):39-43. PubMed ID: 9448171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection.
    Morita K; Tanaka K; Saito S; Kitamura T; Kondo M; Sakaguchi T; Morimoto M; Sekihara H
    J Clin Gastroenterol; 1998 Mar; 26(2):135-40. PubMed ID: 9563926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.
    Xie Y; Xu DZ; Lu ZM; Luo KX; Jia JD; Wang YM; Zhao GZ; Zhang SL; Zhang DZ
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):213-9. PubMed ID: 15908318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy.
    Hino K; Okuda M; Konishi T; Ishiko H; Okita K
    Dig Dis Sci; 1995 Jan; 40(1):14-20. PubMed ID: 7821101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.
    Su PY; Yen HH; Hsu YC; Wu SS; Kor CT; Su WW
    Kaohsiung J Med Sci; 2016 Jul; 32(7):381-6. PubMed ID: 27450028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosis.
    Furusyo N; Hayashi J; Ueno K; Sawayama Y; Kawakami Y; Kishihara Y; Kashiwagi S
    Clin Ther; 1997; 19(6):1352-67. PubMed ID: 9444445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy.
    Izopet J; Payen JL; Alric L; Sandres K; Charlet JP; Vinel JP; Duffaut M; Pascal JP; Puel J
    J Med Virol; 1998 Feb; 54(2):86-91. PubMed ID: 9496364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis. The Australian Hepatitis C Study Group.
    Farrell G; Cooksley WG; Dudley FJ; Watson K
    J Viral Hepat; 1997 Sep; 4(5):317-23. PubMed ID: 9310930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment.
    Gerken G; Knolle P; Jakobs S; Meyer zum Büschenfelde KH
    Arch Virol; 1997; 142(3):459-64. PubMed ID: 9349292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.
    Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice.
    Shiffman ML; Ferreira-Gonzalez A; Reddy KR; Sterling RK; Luketic VA; Stravitz RT; Sanyal AJ; Garrett CT; De Medina M; Schiff ER
    Am J Gastroenterol; 2003 May; 98(5):1159-66. PubMed ID: 12809843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-alpha treatment of chronic hepatitis C in children with hemophilia.
    Ko JS; Choe YH; Kim EJ; Lee EH; Jang JJ; Seo JK
    J Pediatr Gastroenterol Nutr; 2001 Jan; 32(1):41-4. PubMed ID: 11176323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels.
    Ohmiya M; Hayashi J; Ueno K; Furusyo N; Sawayama Y; Kawakami Y; Kinukawa N; Kashiwagi S
    Dig Dis Sci; 2000 Oct; 45(10):1953-8. PubMed ID: 11117566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy].
    Osada T; Iwabuchi S; Takatori M; Murayama M; Iino S
    Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HCV].
    Tsujii H; Yoshikawa M; Nakano H
    Rinsho Byori; 1993 Nov; 41(11):1232-9. PubMed ID: 8283800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.
    Fukutomi T; Fukutomi M; Iwao M; Watanabe H; Tanabe Y; Hiroshige K; Kinukawa N; Nakamuta M; Nawata H
    Med Sci Monit; 2000; 6(4):692-8. PubMed ID: 11208393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C.
    Karino Y; Toyota J; Sugawara M; Miyazaki K; Kuwata Y; Yamazaki K; Sato T; Ohmura T; Matsushima T
    J Gastroenterol Hepatol; 2003 Apr; 18(4):404-10. PubMed ID: 12653888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
    Yao GB; Fu XX; Tian GS; Xu DZ; Hao LJ; Huangfu YS; Su CX
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.